AlphaFold predicted structure
DARS2 · Q6PI48


Mean pLDDT
89.2/ 100
Confident
645 residues
Confidence breakdown
- Very high(≥ 90)78%
- Confident(70–90)13%
- Low(50–70)2%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
aspartyl-tRNA synthetase 2, mitochondrial
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Adult onset leukodystrophy
BIALLELIC, autosomal or pseudoautosomalAdult onset neurodegenerative disorder
BIALLELIC, autosomal or pseudoautosomalAtaxia and cerebellar anomalies - narrow panel
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHereditary ataxia
BIALLELIC, autosomal or pseudoautosomalHereditary ataxia with onset in adulthood
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy
BIALLELIC, autosomal or pseudoautosomal+9 more panels — install the extension to see the full list inline on any page.
Leukoencephalopathy with brain stem and spinal cord involvement - high lactate
leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome
neurodegenerative disease
hereditary disease
gout
Gait ataxia
EMG: axonal abnormality
Impaired vibration sensation in the lower limbs
Gait imbalance
hypertensive disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Aspartate--tRNA ligase, mitochondrial
Catalyzes the attachment of aspartate to tRNA(Asp) in a two-step reaction: aspartate is first activated by ATP to form Asp-AMP and then transferred to the acceptor end of tRNA(Asp)
DARS2 · Q6PI48


Mean pLDDT
89.2/ 100
Confident
645 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0